Credit Suisse Ag A Ikido Pharma Inc. Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
Shares
1 transactions
Others Institutions Holding AIKI
# of Institutions
16Shares Held
459KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA193KShares$734,8890.0% of portfolio
-
Black Rock Inc. New York, NY72.5KShares$275,5720.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny46.9KShares$178,3180.0% of portfolio
-
Geode Capital Management, LLC Boston, MA43.4KShares$164,8020.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX39.8KShares$151,3650.0% of portfolio
About AIkido Pharma Inc.
- Ticker AIKI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,485,100
- Market Cap $20.8M
- Description
- AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...